GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » ROE % Adjusted to Book Value

Noile-Immune Biotech (TSE:4893) ROE % Adjusted to Book Value : -16.44% (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Noile-Immune Biotech ROE % Adjusted to Book Value?

Noile-Immune Biotech's ROE % for the quarter that ended in Mar. 2024 was -24.66%. Noile-Immune Biotech's PB Ratio for the quarter that ended in Mar. 2024 was 1.50. Noile-Immune Biotech's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -16.44%.


Noile-Immune Biotech ROE % Adjusted to Book Value Historical Data

The historical data trend for Noile-Immune Biotech's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noile-Immune Biotech ROE % Adjusted to Book Value Chart

Noile-Immune Biotech Annual Data
Trend Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
- - - -14.06

Noile-Immune Biotech Quarterly Data
Dec20 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only - -5.23 -0.35 -11.92 -16.44

Competitive Comparison of Noile-Immune Biotech's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Noile-Immune Biotech's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Noile-Immune Biotech's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Noile-Immune Biotech's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Noile-Immune Biotech's ROE % Adjusted to Book Value falls into.



Noile-Immune Biotech ROE % Adjusted to Book Value Calculation

Noile-Immune Biotech's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-22.63% / 1.61
=-14.06%

Noile-Immune Biotech's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-24.66% / 1.50
=-16.44%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Noile-Immune Biotech ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Noile-Immune Biotech's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Noile-Immune Biotech (TSE:4893) Business Description

Traded in Other Exchanges
N/A
Address
2-12-10 Shiba-Daimon, Minato-ku, Tokyo, JPN, 105-0012
Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.

Noile-Immune Biotech (TSE:4893) Headlines

No Headlines